# TevaGastrim for Stem Cell Mobilization Sibling Donors

> **NCT01542944** · PHASE2 · COMPLETED · sponsor: **Sheba Medical Center** · enrollment: 24 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- Myelodysplastic Syndrome

## Interventions

- **DRUG:** TevaGastrim

## Key facts

- **NCT ID:** NCT01542944
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01542944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01542944, "TevaGastrim for Stem Cell Mobilization Sibling Donors". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01542944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*